Form 4: USANA CEO Kevin Guest Exercises RSUs, Sells Shares for Tax

USANA Health Sciences CEO and Executive Chairman Kevin Guest converted restricted stock units into common stock and subsequently sold a portion to cover tax obligations over three days in February 2026.

Summary

• Kevin Guest, CEO & Executive Chairman of USANA Health Sciences Inc. (USNA), engaged in multiple transactions involving company common stock and restricted stock units (RSUs).
• On February 6, 2026, 12,061 restricted stock units (granted February 6, 2023) vested and converted into common stock. Concurrently, 5,345 shares were disposed of at $21.34 per share to cover tax liabilities, resulting in 34,498 shares of common stock beneficially owned.
• On February 7, 2026, 6,601 restricted stock units (granted February 7, 2022) vested and converted into common stock. Concurrently, 2,796 shares were disposed of at $21.34 per share to cover tax liabilities, resulting in 38,303 shares of common stock beneficially owned.
• On February 8, 2026, 4,425 restricted stock units (granted February 8, 2024) vested and converted into common stock. Concurrently, 1,875 shares were disposed of at $21.34 per share to cover tax liabilities, resulting in 40,853 shares of common stock beneficially owned.
• Following these transactions, Kevin Guest directly beneficially owned 40,853 shares of common stock and 52,336 restricted stock units.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and expected insider transaction, reflecting the normal course of executive compensation through RSU vesting and subsequent tax-related share dispositions. The use of a 10b5-1 plan adds transparency and predictability.

Positives

• The vesting of restricted stock units indicates continued long-term incentive alignment between the CEO and shareholders.
• The conversion of RSUs into common stock increases the CEO's direct ownership of company shares, net of tax-related dispositions.

Negatives

• A portion of the newly vested shares was sold to cover tax obligations, resulting in a reduction of the total shares acquired from the RSU conversion.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving RSU vesting and subsequent tax-related sales, are common occurrences across all industries for executive compensation. These transactions are typically pre-scheduled under Rule 10b5-1 plans to avoid accusations of trading on material non-public information.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of restricted stock units as a component of executive compensation is a standard practice across publicly traded companies, aligning executive incentives with long-term shareholder value.
• The disposition of shares to cover tax liabilities upon vesting is also a routine and expected event, consistent with compensation practices at companies like Apple (AAPL), Microsoft (MSFT), and Google (GOOGL) where executives frequently sell shares post-vesting to manage tax obligations.

Stakeholder Impact

• Shareholders: The transactions demonstrate ongoing executive compensation and alignment through equity, with a portion of shares sold to cover taxes, which is a standard practice.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details routine, pre-scheduled insider transactions related to executive compensation (RSU vesting and tax-related sales). Such events are generally non-discretionary and do not typically signal a change in the company's fundamental outlook or management's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

USANA Health Sciences, USNA, Kevin Guest, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Sale, Tax Withholding, Executive Compensation, Corporate Governance, 10b5-1 Plan